SLS Sellas Life Sciences Group Inc
Company Analysis
Latest News
🟢 Sellas Life Sciences is trading 7.7% up today ahead of pivotal leukemia trial survival readout
Sellas Life Sciences is trading 7.7% up at $12.65 as traders reposition ahead of a pivotal survival readout from the Phase 3 REGAL trial. • The upcoming data...
Sellas Life Sciences Slides 6% as the Biggest Binary Bet in Small-Cap Biotech Inches Toward a Verdict — Is the Market Pricing It Right?
Shares of Sellas Life Sciences (SLS) dropped to $12.03, down 6.0%, as traders continue to jostle for position ahead of what could be the most consequential...
🔴 Sellas Life Sciences is trading 6.6% down today as traders take profits ahead of trial results
Sellas Life Sciences is trading 6.6% down today at $12.03 as investors rebalance risk and take profits following a period of heavy volatility. • Shares are...
Sellas Life Sciences surges, as $5.8M options bet precedes leukemia trial results
Sellas Life Sciences (SLS) shares rose after Armstrong Advisory Group disclosed a new institutional position. The stock also experienced a significant increase...
🔴 Sellas Life Sciences is trading 5.2% down
Sellas Life Sciences is trading at $12.69, down 5.2% from a comparison close of $13.39 during regular trading. This is a price-action follow-up, so a separate...
🟢 Sellas Life Sciences is trading 4.0% up today amid trading volatility and biotech sector positioning
Sellas Life Sciences is trading at $13.13 (+4.04%) as the stock gains momentum following a volatile stretch and a move off its recent lows. • The stock has...
🔴 Sellas Life Sciences Shares Decline Amid Volatility as Investors Weigh Phase 3 REGAL Trial Progress and Conflicting Analyst Outlooks
• Sellas Life Sciences is trading at $12.85 (-4.89%) today, extending a sharp pullback from early July trading. • The decline comes as investors continue to...
🟢 Sellas Life Sciences is trading 4.9% up today as it rebounds amid broader market gains
Sellas Life Sciences is trading 4.9% higher at $14.44 as the stock rebounds from recent volatility despite a lack of fresh company-specific catalysts. • The...
🔴 SLS extends move to 7.4% down
SLS is trading at $12.50, down 7.4% versus the comparison close of $13.50 during regular trading. This is a price-movement alert; no separate company-specific...
🔴 SLS is trading 4.3% down today on profit-taking following a multi-day rally and analyst-driven momentum
SLS is trading 4.3% down at $12.92 as investors lock in profits following a sharp multi-day rally fueled by bullish analyst coverage and anticipation of Phase...
Sellas Gets a 150% Price Target Hike — But Can a Cancer Vaccine Trial Deliver the Goods?
Shares of Sellas Life Sciences surged 8.2% to $14.61 as investors digested a dramatic vote of confidence from Wall Street: Alliance Global analyst James...
🟢 SLS is trading 8.2% up today after Alliance Global raised its price target to $25
SLS is trading 8.2% higher at $14.61 following a significant price target increase from Alliance Global. • Alliance Global raised its price target on Sellas...
🟢 SLS makes sharp 10.3% jump
SLS is trading at $14.63, up 10.3% versus the comparison close of $13.27 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 SLS extends move to 7.0% up
SLS is trading at $14.20, up 7.0% versus the comparison close of $13.27 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 SLS is trading 4.7% up today with no clear new catalyst
SLS is trading 4.7% up now at $13.90 after sharp swings over the past week, including a 24.7% jump on June 29 and a 10.1% drop on July 1. There are no fresh...
🔴 SLS makes sharp 11.4% drop
SLS is trading at $13.08, down 11.4% versus the comparison close of $14.76 during regular trading. This is a price-movement alert; no separate company-specific...
🔴 SLS extends move to 5.4% down
SLS is trading at $13.96, down 5.4% versus the comparison close of $14.76 during pre-market. This is a price-movement alert; no separate company-specific...
🔴 SLS is trading 4.3% down today as traders lock in profits after REGAL trial rally
SLS is trading at $14.12 (4.3% down) as the stock pulls back following a significant multi-day rally driven by Phase 3 REGAL trial optimism. • The stock...
🔴 SLS makes sharp 10.3% drop
SLS is trading at $13.86, down 10.3% versus the comparison close of $15.45 during regular trading. This is a price-movement alert; no separate company-specific...
🔴 SLS is trading 6.2% down today as buyout speculation cools and traders take profits
SLS is trading 6.2% down today at $14.49 as buyout speculation cools and traders take profits following a sharp multi-day rally to 52-week highs. • The stock...